This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Wayne Marasco
Professor of Medicine at Dana-Farber Cancer Institute


Dr. Wayne A. Marasco, M.D., Ph.D. is Professor of Medicine at Harvard Medical School (HMS) and Lab Chief in the Department of Cancer Immunology & Virology at Dana-Farber Cancer Institute. He is also a Primary Faculty Member of Harvard Stem Cell Institute (HSCI). Dr. Marasco is board certified in internal medicine and infectious diseases. His academic clinical practice at the Dana-Farber/Brigham & Women’s Hospital is in the care of immunocompromised patients including cancer patients undergoing chemo- and immunotherapy as well as bone marrow and solid organ transplant patients. Dr. Marasco is a pioneer in the field of human antibody engineering and cellular//stem cell therapies holds over 90 patents. Dr. Marasco is senior author of over 175 peer reviewed publications, chapters, books and monographs. Dr. Marasco’s laboratory ( is primarily focused on therapeutic human monoclonal antibody (mAb) and cellular (CAR T) immunotherapies to prevent and treat global and emerging infectious diseases and cancer. His areas of expertise in infectious diseases include influenza, coronavirus and flavivirus infections. His laboratory discovered the broadly neutralizing antibodies against the HA-stem of influenza, fusion loop of flaviviruses (Denge, Zika viruses) and neutralizing anti-coronavirus mAbs against SARS and MERS.

Agenda Sessions

  • Responding to the COVID-19 Pandemic with Antibodies, Small Molecule Drugs and Vaccines

  • Studies of Our Human Neutralizing Antibody Discovery Campaigns Against SARS, MERS and the Emerging SARS-CoV2 Pandemic: What We Have Learned

    On Demand